Found 13 matching trials
Predictors of Lorcaserin-Induced Weight Loss PHASE4 This two-phase study aims to explore ways to predict who will respond well ...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus PHASE3 The purpose of this study is to assess the weight loss effect of lorcaserin...
Show More Location
Arena Pharmaceuticals, Inc.
Learn More & Join Trial
Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy PHASE2 A Randomized Phase II study Comparing Lorcaserin versus Duloxetine for the ...
Show More Location
Cancer Treatment Centers of America - Atlanta
Learn More & Join Trial
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors PHASE4 This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Show More Location
Advanced Cardiovascular, LLC
Learn More & Join Trial
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation PHASE2 In smokers who are motivated to stop smoking, treatment with lorcaserin com...
Show More Location
Pharmacology Research Institute
Learn More & Join Trial
Real-World Evidence on the Cardiovascular Safety of CONTRAVE® in the United States (U.S.) N/A The fixed-dose combination of naltrexone 8mg and bupropion 90mg extended-re...
Show More Location
Currax Pharmaceuticals
Learn More & Join Trial
Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder PHASE2 This study proposes to recruit patients with Opioid Use Disorder (OUD) seek...
Show More Location
Substance Treatment and Research Service (STARS), Columbia University
Learn More & Join Trial
Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management PHASE3 Currently in the United States about 97 million adults are considered obese...
Show More Learn More & Join Trial
A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome PHASE3 The primary purpose of the study is to demonstrate that lorcaserin has supe...
Show More Location
Children's of Alabama / University of Alabama at Birmingham
Learn More & Join Trial
Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder PHASE1 The overall goal of this project is to develop initial human data on effect...
Show More Location
Virginia Commonwealth University
Learn More & Join Trial